Role of estrogen receptor alpha in human cervical cancer-associated fibroblasts: a transcriptomic study

Tumor Biology

Volumn 37, Issue 4, 2016, Pages 4409-4420

  Kumar, Mahesh M ^a   Davuluri, Sravanthi ^b,c   Poojar, Sridhar ^a   Mukherjee, Geetashree ^a   Bajpai, Akhilesh Kumar ^b,c   Bafna, Uttam Dungarmal ^a   Devi, Uma K ^a   Kallur, Pramod P R ^a   Kshitish, Acharya K ^c,d   Jayshree, R S ^a  

^a KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^b VIT UNIVERSITY   (India)

^c Pvt Ltd   (India)

^d Institute of Bioinformatics and Applied Biotechnology   (India)

Author keywords

Cancer Associated Fibroblasts; Cervical cancer; Estrogen Receptor Alpha; Estrogen Receptor antagonists; ICI 182,780; MPP Methyl Piperidino Pyrazole

Indexed keywords

ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; TRANSCRIPTOME;

ACTA2 GENE; ARTICLE; CANCER GROWTH; CERVICAL CANCER ASSOCIATED FIBROBLAST; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ER ALPHA GENE; ESPL1 GENE; EX VIVO STUDY; FAP GENE; FEMALE; FIBROBLAST; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE LOCATION; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INPP4B GENE; INTRACELLULAR SIGNALING; KRT5 GENE; MAP2K1 GENE; ORC1L GENE; PDGFR ALPHA GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SERPINE1 GENE; SHC4 GENE; TRANSCRIPTOMICS; VIM GENE; CANCER ASSOCIATED FIBROBLAST; CANCER STAGING; CASE CONTROL STUDY; CELL CULTURE; GENE EXPRESSION REGULATION; GENE ONTOLOGY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX; UTERINE CERVIX TUMOR;

CANCER-ASSOCIATED FIBROBLASTS; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CELLS, CULTURED; CERVIX UTERI; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE ONTOLOGY; HUMANS; NEOPLASM STAGING; SIGNAL TRANSDUCTION; TRANSCRIPTOME; UTERINE CERVICAL NEOPLASMS;

EID: 84945157344     PISSN: 10104283     EISSN: 14230380     Source Type: Journal    
DOI: 10.1007/s13277-015-4257-6     Document Type: Article

References (40)

1. Jayshree RS, Sreenivas A, Tessy M, Krishna S. Cell intrinsic and extrinsic factors in cervical carcinogenesis. Indian J Med Res. 2009;130:286–95.
2. Paulsson J, Micke P. Prognostic relevance of cancer-associated fibroblasts in human cancer. Semin Cancer Biol. 2014;25:61–8.
3. Spano D, Zollo M. Tumor microenvironment: a main actor in the metastasis process. Clin Exp Metastasis. 2012;29:381–95.
4. Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO, et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha. Science. 2010;330:827–30.
5. Erez N, Truitt M, Olson P, Arron ST, Hanahan D. Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell. 2010;17:135–47.
6. Arbeit JM, Münger K, Howley PM, Hanahan D. Progressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice. J Virol. 1994;68:4358–68.
7. Chung SH, Wiedmeyer K, Shai A, Korach KS, Lambert PF. Requirement for estrogen receptor alpha in a mouse model for human papillomavirus-associated cervical cancer. Cancer Res. 2008;68:9928–34.
8. Chung SH, Shin MK, Korach KS, Lambert PF. Requirement for stromal estrogen receptor alpha in cervical neoplasia. Horm Cancer. 2013;4:50–9.
9. Kwasniewska A, Postawski K, Gozdzicka-Jozefiak A, Kwasniewski W, Grywalska E, Zdunek M, et al. Estrogen and progesterone receptor expression in HPV-positive and HPV-negative cervical carcinomas. Oncol Rep. 2011;26:153–60.
10. den Boon JA, Pyeon D, Wang SS, Horswill M, Schiffman M, Sherman M, et al. Molecular transitions from papillomavirus infection to cervical precancer and cancer: role of stromal estrogen receptor signaling. Proc Natl Acad Sci U S A. 2015;112(25):E3255–64.
11. Adurthi S, Krishna S, Mukherjee G, Bafna UD, Devi U, Jayshree RS. Regulatory T cells in a spectrum of HPV-induced cervical lesions: cervicitis, cervical intraepithelial neoplasia and squamous cell carcinoma. Am J Reprod Immunol. 2008;60:55–65.
12. Ma CX, Adjei AA, Salavaggione OE, Coronel J, Pelleymounter L, Wang L, et al. Human aromatase: gene resequencing and functional genomics. Cancer Res. 2005;65:11071–1182.
13. Osborne CK, Wakeling A, Nicholson RI. Fulvestrant: an oestrogen receptor antagonist with a novel mechanism of action. Br J Cancer. 2004;90 Suppl 1:S2–6.
14. Tai P, Wang J, Jin H, Song X, Yan J, Kang Y, et al. Induction of regulatory T cells by physiological level estrogen. J Cell Physiol. 2008;214:456–64.
15. Meerloo JV, Kaspers GJL, Cloos J. Cell sensitivity assays: the MTT assay. Cancer cell culture. Methods Mol Biol. 2011;731:237–45.
16. R Development Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0, 2010; URL http://www.R-project.org/.
17. Smyth GK. LIMMA: linear models for microarray data. Bioinformatics and computational biology solutions using R and Bioconductor. New York: Springer; 2005. p. 397–420.
18. Chen J, Bardes EE, Aronow BJ, Jegga AG. ToppGene Suite for gene list enrichment analysis and candidate gene prioritization. Nucleic Acids Res. 2009;37 suppl 2:W305–11.
19. De Veirman K, Rao L, De Bruyne E, Menu E, Van Valckenborgh E, Van Riet I, et al. Cancer associated fibroblasts and tumor growth: focus on multiple myeloma. Cancers (Basel). 2014;6:1363–81.
20. Bowden PE, Woodworth CD, Doniger J, DiPaolo JA. Down-regulation of keratin 14 gene expression after v-Ha-ras transfection of human papillomavirus-immortalized human cervical epithelial cells. Cancer Res. 1992;52:5865–71.
21. Lin CY, Ström A, Vega VB, Kong SL, Yeo AL, Thomsen JS, et al. Discovery of estrogen receptor alpha target genes and response elements in breast tumor cells. Genome Biol. 2004;5:R66.
22. Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28:27–30.
23. Chu TY, Yang JT, Huang TH, Liu HW. Crosstalk with cancer-associated fibroblasts increases the growth and radiation survival of cervical cancer cells. Radiat Res. 2014;181:540–7.
24. Wilson CA, Cajulis EE, Green JL, Olsen TM, Chung YA, Damore MA, et al. HER-2 overexpression differentially alters transforming growth factor-beta responses in luminal versus mesenchymal human breast cancer cells. Breast Cancer Res. 2005;7:R1058–79.
25. Mukaida N, Sasaki S, Baba T. Chemokines in cancer development and progression and their potential as targeting molecules for cancer treatment. Mediat Inflamm. 2014;2014:170381.
26. Atsumi T, Singh R, Sabharwal L, Bando H, Meng J, Arima Y, et al. Inflammation amplifier, a new paradigm in cancer biology. Cancer Res. 2014;74:8–14.
27. Moreno V, Bosch FX, Munoz N, et al. Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: the IARC multicentric case–control study. Lancet. 2002;359:1085–92.
28. Munoz N, Franceschi S, Bosetti C, et al. Role of parity and human papillomavirus in cervical cancer: the IARC multicentric case–control study. Lancet. 2002;359:1093–101.
29. Witsch E, Sela M, Yarden Y. Roles for growth factors in cancer progression. Physiology (Bethesda). 2010;25:85–101.
30. Zhang X, Diaz MR, Yee D. Fulvestrant regulates epidermal growth factor (EGF) family ligands to activate EGF receptor (EGFR) signaling in breast cancer cells. Breast Cancer Res Treat. 2013;139:351–60.
31. Murata T, Mizushima H, Chinen I, Moribe H, Yagi S, Hoffman RM, et al. HB-EGF and PDGF mediate reciprocal interactions of carcinoma cells with cancer-associated fibroblasts to support progression of uterine cervical cancers. Cancer Res. 2011;71:6633–42.
32. Shen XJ, KeGu J-PS, Yao J-Q, Wu J-C. Increased expression of stanniocalcin 2 is associated with tumor progression after radiotherapy in patients with cervical carcinoma. Int J Clin Exp Pathol. 2014;7:8770–6.
33. Woodworth CD, McMullin E, Iglesias M, Plowman GD. Interleukin 1 alpha and tumor necrosis factor alpha stimulate autocrine amphiregulin expression and proliferation of human papillomavirus-immortalized and carcinoma-derived cervical epithelial cells. Proc Natl Acad Sci U S A. 1995;92:2840–4.
34. Ju X, Katiyar S, Wang C, Liu M, Jiao X, Li S, et al. Akt1 governs breast cancer progression in vivo. Proc Natl Acad Sci U S A. 2007;104:7438–43.
35. De Boeck A, Hendrix A, Maynard D, Van Bockstal M, Daniëls A, Pauwels P, et al. Differential secretome analysis of cancer-associated fibroblasts and bone marrow-derived precursors to identify microenvironmental regulators of colon cancer progression. Proteomics. 2013;13:379–88.
36. Bai L, Merchant JL. A role for CITED2, a CBP/p300 interacting protein, in colon cancer cell invasion. FEBS Lett. 2007;581:5904–10.
37. Augsten M. Cancer-associated fibroblasts as another polarized cell type of the tumor microenvironment. Front Oncol. 2014;4:62–71.
38. Ogo Y, Taniuchi S, Ojima F, Hayashi S, Murakami I, Saito Y, et al. IGF-1 gene expression is differentially regulated by estrogen receptors α and β in mouse endometrial stromal cells and ovarian granulosa cells. J Reprod Dev. 2014;60:216–23.
39. Pavlidis P, Noble WS. Matrix2png: a utility for visualizing matrix data. Bioinformatics. 2003;19:295–96.
40. Oliveros, J.C. Venny. An interactive tool for comparing lists with Venn Diagrams. 2007 http://bioinfogp.cnb.csic.es/tools/venny/index.html.